Protective efficacy of two novel DNA vaccines expressing<i>Toxoplasma gondii</i>rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice
Nian‐Zhang Zhang(Lanzhou Veterinary Research Institute), Xing‐Quan Zhu(Shanxi Agricultural University), Meng Wang(Lanzhou Veterinary Research Institute), Jia Chen(Chinese Academy of Sciences), Ying Xu(Zhejiang University), Eskild Petersen(Roskilde University), Si‐Yang Huang(Hunan Normal University)
Cited by 55
Related Papers
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
|Nature Communications|2018|2.1k
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
Rapid and Visual Detection of Trichinella Spp. Using a Lateral Flow Strip-Based Recombinase Polymerase Amplification (LF-RPA) Assay
|Frontiers in Cellular and Infection Microbiology|2019|215
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives
|Trends in Parasitology|2019|201
Vaccines against<i>Toxoplasma gondii</i>: new developments and perspectives
|Expert Review of Vaccines|2013|157